These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

87 related items for PubMed ID: 16759104

  • 1. Fancy bioisosteres: novel paracyclophane derivatives as super-affinity dopamine D3 receptor antagonists.
    Schlotter K, Boeckler F, Hübner H, Gmeiner P.
    J Med Chem; 2006 Jun 15; 49(12):3628-35. PubMed ID: 16759104
    [Abstract] [Full Text] [Related]

  • 2. Pharmacophore-guided drug discovery investigations leading to bioactive 5-aminotetrahydropyrazolopyridines. Implications for the binding mode of heterocyclic dopamine D3 receptor agonists.
    Elsner J, Boeckler F, Heinemann FW, Hübner H, Gmeiner P.
    J Med Chem; 2005 Sep 08; 48(18):5771-9. PubMed ID: 16134944
    [Abstract] [Full Text] [Related]

  • 3. First structure-activity relationship study on dopamine D3 receptor agents with N-[4-(4-arylpiperazin-1-yl)butyl]arylcarboxamide structure.
    Leopoldo M, Lacivita E, Colabufo NA, Contino M, Berardi F, Perrone R.
    J Med Chem; 2005 Dec 15; 48(25):7919-22. PubMed ID: 16335915
    [Abstract] [Full Text] [Related]

  • 4. Fancy bioisosteres: synthesis, SAR, and pharmacological investigations of novel nonaromatic dopamine D3 receptor ligands.
    Lenz C, Boeckler F, Hübner H, Gmeiner P.
    Bioorg Med Chem; 2005 Jul 15; 13(14):4434-42. PubMed ID: 15908220
    [Abstract] [Full Text] [Related]

  • 5. Novel pyridylmethylamines as highly selective 5-HT(1A) superagonists.
    Bollinger S, Hübner H, Heinemann FW, Meyer K, Gmeiner P.
    J Med Chem; 2010 Oct 14; 53(19):7167-79. PubMed ID: 20860381
    [Abstract] [Full Text] [Related]

  • 6. Fancy bioisosteres: metallocene-derived G-protein-coupled receptor ligands with subnanomolar binding affinity and novel selectivity profiles.
    Schlotter K, Boeckler F, Hübner H, Gmeiner P.
    J Med Chem; 2005 Jun 02; 48(11):3696-9. PubMed ID: 15916420
    [Abstract] [Full Text] [Related]

  • 7. CoMFA and CoMSIA investigations revealing novel insights into the binding modes of dopamine D3 receptor agonists.
    Boeckler F, Ohnmacht U, Lehmann T, Utz W, Hübner H, Gmeiner P.
    J Med Chem; 2005 Apr 07; 48(7):2493-508. PubMed ID: 15801839
    [Abstract] [Full Text] [Related]

  • 8. 1,1'-Disubstituted ferrocenes as molecular hinges in mono- and bivalent dopamine receptor ligands.
    Huber D, Hübner H, Gmeiner P.
    J Med Chem; 2009 Nov 12; 52(21):6860-70. PubMed ID: 19807103
    [Abstract] [Full Text] [Related]

  • 9. Cyanoindole derivatives as highly selective dopamine D(4) receptor partial agonists: solid-phase synthesis, binding assays, and functional experiments.
    Hübner H, Kraxner J, Gmeiner P.
    J Med Chem; 2000 Nov 16; 43(23):4563-9. PubMed ID: 11087581
    [Abstract] [Full Text] [Related]

  • 10. N-(omega-(4-(2-methoxyphenyl)piperazin-1-yl)alkyl)carboxamides as dopamine D2 and D3 receptor ligands.
    Hackling A, Ghosh R, Perachon S, Mann A, Höltje HD, Wermuth CG, Schwartz JC, Sippl W, Sokoloff P, Stark H.
    J Med Chem; 2003 Aug 28; 46(18):3883-99. PubMed ID: 12930150
    [Abstract] [Full Text] [Related]

  • 11. Exploration of the amine terminus in a novel series of 1,2,4-triazolo-3-yl-azabicyclo[3.1.0]hexanes as selective dopamine D3 receptor antagonists.
    Micheli F, Arista L, Bertani B, Braggio S, Capelli AM, Cremonesi S, Di-Fabio R, Gelardi G, Gentile G, Marchioro C, Pasquarello A, Provera S, Tedesco G, Tarsi L, Terreni S, Worby A, Heidbreder C.
    J Med Chem; 2010 Oct 14; 53(19):7129-39. PubMed ID: 20839775
    [Abstract] [Full Text] [Related]

  • 12. Novel heterocyclic trans olefin analogues of N-{4-[4-(2,3-dichlorophenyl)piperazin-1-yl]butyl}arylcarboxamides as selective probes with high affinity for the dopamine D3 receptor.
    Grundt P, Carlson EE, Cao J, Bennett CJ, McElveen E, Taylor M, Luedtke RR, Newman AH.
    J Med Chem; 2005 Feb 10; 48(3):839-48. PubMed ID: 15689168
    [Abstract] [Full Text] [Related]

  • 13. Heterocyclic analogues of N-(4-(4-(2,3-dichlorophenyl)piperazin-1-yl)butyl)arylcarboxamides with functionalized linking chains as novel dopamine D3 receptor ligands: potential substance abuse therapeutic agents.
    Grundt P, Prevatt KM, Cao J, Taylor M, Floresca CZ, Choi JK, Jenkins BG, Luedtke RR, Newman AH.
    J Med Chem; 2007 Aug 23; 50(17):4135-46. PubMed ID: 17672446
    [Abstract] [Full Text] [Related]

  • 14. Dopamine/serotonin receptor ligands. 13: Homologization of a benzindoloazecine-type dopamine receptor antagonist modulates the affinities for dopamine D(1)-D(5) receptors.
    Enzensperger C, Lehmann J.
    J Med Chem; 2006 Oct 19; 49(21):6408-11. PubMed ID: 17034146
    [Abstract] [Full Text] [Related]

  • 15. Fluoro-substituted phenylazocarboxamides: Dopaminergic behavior and N-arylating properties for irreversible binding.
    Bartuschat AL, Schellhorn T, Hübner H, Gmeiner P, Heinrich MR.
    Bioorg Med Chem; 2015 Jul 15; 23(14):3938-47. PubMed ID: 25564378
    [Abstract] [Full Text] [Related]

  • 16. Bioisosteric replacement leading to biologically active [2.2]paracyclophanes with altered binding profiles for aminergic G-protein-coupled receptors.
    Skultety M, Hübner H, Löber S, Gmeiner P.
    J Med Chem; 2010 Oct 14; 53(19):7219-28. PubMed ID: 20839776
    [Abstract] [Full Text] [Related]

  • 17. F15063, a potential antipsychotic with D2/D3 antagonist, 5-HT 1A agonist and D4 partial agonist properties. I. In vitro receptor affinity and efficacy profile.
    Newman-Tancredi A, Assié MB, Martel JC, Cosi C, Slot LB, Palmier C, Rauly-Lestienne I, Colpaert F, Vacher B, Cussac D.
    Br J Pharmacol; 2007 May 14; 151(2):237-52. PubMed ID: 17375087
    [Abstract] [Full Text] [Related]

  • 18. Analogues of FAUC 73 revealing new insights into the structural requirements of nonaromatic dopamine D3 receptor agonists.
    Lenz C, Boeckler F, Hübner H, Gmeiner P.
    Bioorg Med Chem; 2004 Jan 02; 12(1):113-7. PubMed ID: 14697776
    [Abstract] [Full Text] [Related]

  • 19. Fancy bioisosteres: synthesis and dopaminergic properties of the endiyne FAUC 88 as a novel non-aromatic D3 agonist.
    Lenz C, Haubmann C, Hübner H, Boeckler F, Gmeiner P.
    Bioorg Med Chem; 2005 Jan 03; 13(1):185-91. PubMed ID: 15582463
    [Abstract] [Full Text] [Related]

  • 20. Discovery of dopamine D₄ receptor antagonists with planar chirality.
    Sanna F, Ortner B, Hübner H, Löber S, Tschammer N, Gmeiner P.
    Bioorg Med Chem; 2013 Apr 01; 21(7):1680-4. PubMed ID: 23428965
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.